首页 | 本学科首页   官方微博 | 高级检索  
     


Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)
Authors:Verheus Martijn  Peeters Petra H M  Rinaldi Sabina  Dossus Laure  Biessy Carine  Olsen Anja  Tjønneland Anne  Overvad Kim  Jeppesen Majbritt  Clavel-Chapelon Françoise  Téhard Bertrand  Nagel Gabriele  Linseisen Jakob  Boeing Heiner  Lahmann Petra H  Arvaniti Athina  Psaltopoulou Theodora  Trichopoulou Antonia  Palli Domenico  Tumino Rosario  Panico Salvatore  Sacerdote Carlotta  Sieri Sabina  van Gils Carla H  Bueno-de-Mesquita Bas H  González Carlos A  Ardanaz Eva  Larranaga Nera  Garcia Carmen Martinez  Navarro Carmen  Quirós J Ramón  Key Tim  Allen Naomi  Bingham Sheila  Khaw Kay-Tee  Slimani Nadia  Riboli Elio  Kaaks Rudolf
Affiliation:International Agency for Research on Cancer (IARC-WHO), Lyon, France.
Abstract:It has been hypothesized that chronic hyperinsulinemia, a major metabolic consequence of physical inactivity and excess weight, might increase breast cancer risk by direct effects on breast tissue or indirectly by increasing bioavailable levels of testosterone and estradiol. Within the European Prospective Investigation into Cancer and Nutrition (EPIC), we measured serum levels of C-peptide--a marker for pancreatic insulin secretion--in a total of 1,141 incident cases of breast cancer and 2,204 matched control subjects. Additional measurements were made of serum sex hormone binding globulin (SHBG) and sex steroids. Conditional logistic regression models were used to estimate breast cancer risk for different levels of C-peptide. C-peptide was inversely correlated with SHBG and hence directly correlated with free testosterone among both pre and postmenopausal women. C-peptide and free estradiol also correlated positively, but only among postmenopausal women. Elevated serum C-peptide levels were associated with a nonsignificant reduced risk of breast cancer diagnosed up to the age of 50 years [odds ratio (OR)=0.70, (95% confidence interval (CI), 0.39-1.24); ptrend=0.05]. By contrast, higher levels of C-peptide were associated with an increase of breast cancer risk among women above 60 years of age, however only among those women who had provided a blood sample under nonfasting conditions [OR=2.03, (95% CI, 1.20-3.43); ptrend=0.01]. Our results do not support the hypothesis that chronic hyperinsulinemia generally increases breast cancer risk, independently of age. Nevertheless, among older, postmenopausal women, hyperinsulinemia might contribute to increasing breast cancer risk.
Keywords:C‐peptide  breast cancer  prospective  cohort  EPIC
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号